Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals focuses on developing innovative therapies for adults and children with neurological and oncological conditions. The company is a leader in epilepsy and sleep disorders and is expanding its presence in oncology. Jazz Pharmaceuticals explores novel compounds, small molecules, biologics, cannabinoid science, and innovative delivery technologies to bring new treatments to patients with critical unmet needs.